Welcome to our dedicated page for Marsh & Mclennan SEC filings (Ticker: MMC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Marsh & McLennan Companies, Inc. filings document a global professional services firm with businesses in risk, reinsurance and capital, people and investments, and management consulting. The record includes 8-K reports for quarterly and annual operating results, officer appointments and compensation actions, director changes, bylaw amendments, and other material events.
Proxy materials describe annual meeting matters, board governance, executive compensation and stockholder voting. Capital-market filings cover common stock registered on the New York Stock Exchange and NYSE Texas, shelf registration use, underwriting agreements, senior notes, indenture supplements and related exhibits for the company's advisory and consulting businesses.
Marsh & McLennan Companies insider transaction by John Q. Doyle. The filing reports that on 09/02/2025 Mr. Doyle exercised 21,079 stock options with an exercise price of $63.09 and immediately sold 21,079 shares at $205.65 per share. The transactions were executed pursuant to a previously adopted Rule 10b5-1 trading plan. After these transactions Mr. Doyle beneficially owned 87,681.0205 shares of MMC directly. The options exercised were originally granted on May 1, 2016 and vested in four equal annual installments beginning May 1, 2017, with full vesting by 2020.
Marsh & McLennan Companies, Inc. (MMC) filed a Form 144 reporting a proposed sale of 21,079 common shares through Fidelity Brokerage Services (Smithfield, RI) with an aggregate market value of $4,334,896.35. The filing lists the approximate date of sale as 09/02/2025 and reports 491,624,043 shares outstanding, indicating the sale will be executed on the NYSE. The securities are reported as acquired in connection with options granted 05/01/2016, with the acquisition date shown as 09/02/2025 and payment noted as cash. The filer also disclosed a prior sale on 06/02/2025 by John Q. Doyle of 21,080 shares for gross proceeds of $4,891,614.00. The notice includes the standard representation that the selling person does not possess undisclosed material adverse information.
Anthony Anderson, a director of Marsh & McLennan Companies, Inc. (MMC), reported an internal compensation-related acquisition on 08/15/2025. Under the Marsh & McLennan Companies Directors Stock Compensation Plan, 15,487.69 restricted stock units (which convert 1-for-1 into common stock) were credited to his account with dividend equivalents. The filing shows these units are held directly following the transaction and were recorded on a Form 4 signed on 08/18/2025 by an attorney-in-fact. No cash purchase price or sale was reported; the transaction is described as acquisition via dividend equivalents under the directors' plan.
Marsh & McLennan Companies director Deborah C. Hopkins reported receipt of restricted stock units under the company's Directors Stock Compensation Plan that convert 1-for-1 into common stock. The transaction dated 08/15/2025 shows 85.08 underlying shares (acquired with dividend equivalents) and reports 19,752.73 shares beneficially owned following the transaction on a direct basis. The filing was executed by an attorney-in-fact on 08/18/2025. No exercise price or derivative expiration applies because these are restricted stock units that convert to common stock.
Marsh & McLennan Companies director Lloyd M. Yates received restricted stock units under the company's Directors Stock Compensation Plan that convert 1-for-1 into common stock. The Form 4 reports two grant entries tied to director fees and dividend equivalents, showing 174.23 and 43.37 restricted stock units credited, with a reported per-share reference price of $208.055. The report shows the reporting person's beneficial ownership in common stock at 10,243.63 shares following the reported transactions. The filing documents routine, compensation-related equity awards to a director and does not disclose sales, purchases for cash, or other non-compensation transactions.
Report of director equity awards and dividend-equivalent credit. Jane H. Lute, a director of Marsh & McLennan Companies, Inc. (MMC), received restricted stock units under the Marsh & McLennan Companies Directors Stock Compensation Plan with transaction dates of 08/15/2025. One grant shows 130.67 restricted stock units acquired in connection with director fees, and a second entry shows 29.48 restricted stock units acquired from dividend equivalents. The security converts 1-for-1 into MMC common stock. Following these transactions, the reporting person beneficially owned 6,974.89 shares (the filing shows 6,945.41 following the first entry and 6,974.89 after the second). The form was signed by an attorney-in-fact on 08/18/2025.
Marsh & McLennan Companies (MMC) director Steven A. Mills reported an acquisition of company common stock as director compensation. On 08/15/2025 he acquired 204 shares at an average price of $208.055 per share under the Marsh & McLennan Companies Directors Stock Compensation Plan. After the transaction, the filing shows Mr. Mills beneficially owns 3,669.75 shares directly and 47,553 shares indirectly through a trust. The Form 4 was signed by an attorney-in-fact on 08/18/2025 and discloses the acquisition was compensation-related.
Marsh & McLennan Companies director Tamara Ingram reported acquisition of 32.8 restricted stock units under the company's Directors Stock Compensation Plan, treated as converting 1-for-1 into common stock. The units were acquired via dividend equivalents and are recorded with a per-share reference price of $208.055. After this grant the reporting person’s beneficial ownership is shown as 7,616.23 shares (direct).
The Form 4 discloses a routine compensation-related grant to a director rather than an open-market trade, indicating equity received as part of director pay rather than a purchase or sale.
Siegmund Jan, a director of Marsh & McLennan Companies, Inc. (MMC), reported a non-derivative acquisition on 08/15/2025. The filing shows the reporting person received Restricted Stock Units under the Marsh & McLennan Companies Directors Stock Compensation Plan that convert 1-for-1 into common stock. The transaction was recorded as resulting in 933.67 shares beneficially owned following the award and was acquired with dividend equivalents credited to the reporting person’s account. The Form 4 was signed by an attorney-in-fact on 08/18/2025.
The Form 4 shows that Morton O. Schapiro, a director of Marsh & McLennan Companies, Inc. (MMC), received restricted stock units under the companys Directors Stock Compensation Plan on 08/15/2025. Two entries are reported: 198.26 restricted stock units acquired in connection with director fees and 373.86 restricted stock units credited as dividend equivalents. The security converts 1-for-1 into MMC common stock. Following these transactions the filing reports beneficial ownership figures of 86,624.11 and 86,997.97 shares on the respective lines. The Form 4 is signed by an attorney-in-fact on behalf of the reporting person.